204 related articles for article (PubMed ID: 32143615)
21. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients.
Kaplan FS; Kobori JA; Orellana C; Calvo I; Rosello M; Martinez F; Lopez B; Xu M; Pignolo RJ; Shore EM; Groppe JC
Am J Med Genet A; 2015 Oct; 167A(10):2265-71. PubMed ID: 26097044
[TBL] [Abstract][Full Text] [Related]
22. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
[TBL] [Abstract][Full Text] [Related]
23. [Transverse reductional anomaly and atypical fibrodysplasia ossificans progressiva: A case diagnosed late].
Paysal J; Sarret C; Merlin E; Ravazzolo R; Bocciardi R; Garcier JM; Monnot S; Laffargue F; Baujat G; Echaubard S
Arch Pediatr; 2017 Jun; 24(6):547-551. PubMed ID: 28416432
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP).
Kaplan FS; Al Mukaddam M; Pignolo RJ
Bone; 2018 Apr; 109():158-161. PubMed ID: 28600150
[TBL] [Abstract][Full Text] [Related]
25. ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report.
Nakahara Y; Katagiri T; Ogata N; Haga N
Am J Med Genet A; 2014 Jan; 164A(1):220-4. PubMed ID: 24259422
[TBL] [Abstract][Full Text] [Related]
26. Fibrodysplasia ossificans progressiva: The patient voice.
Cali IL; Rossano L
Bone; 2018 Apr; 109():291-294. PubMed ID: 28549688
[TBL] [Abstract][Full Text] [Related]
27. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.
Ravazzolo R; Cappato S; Bocciardi R
Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of 20 years experience of fibrodysplasia ossificans progressiva in Iran: lessons for early diagnosis and prevention.
Raees-Karami SR; Jafarieh H; Ziyayi V; Shekarriz Foumani R; Aghighi Y
Clin Rheumatol; 2012 Jul; 31(7):1133-7. PubMed ID: 22526474
[TBL] [Abstract][Full Text] [Related]
29. Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.
Pignolo RJ; Baujat G; Brown MA; De Cunto C; Di Rocco M; Hsiao EC; Keen R; Al Mukaddam M; Sang KLQ; Wilson A; White B; Grogan DR; Kaplan FS
Orphanet J Rare Dis; 2019 May; 14(1):98. PubMed ID: 31053156
[TBL] [Abstract][Full Text] [Related]
30. Classical and atypical Fibrodysplasia Ossificans Progressiva in India.
Madhuri V; Santhanam M; Sugumar LK; Rajagopal K; Chilbule SK
Ann Hum Genet; 2015 Jul; 79(4):245-52. PubMed ID: 26058333
[TBL] [Abstract][Full Text] [Related]
31. Elevated plasma RANTES in fibrodysplasia ossificans progressiva - A novel therapeutic target?
Grgurević L; Novak R; Trkulja V; Hamzić LF; Hrkač S; Grazio S; Santini M
Med Hypotheses; 2019 Oct; 131():109313. PubMed ID: 31443758
[TBL] [Abstract][Full Text] [Related]
32. Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP).
Hsiao EC; Di Rocco M; Cali A; Zasloff M; Al Mukaddam M; Pignolo RJ; Grunwald Z; Netelenbos C; Keen R; Baujat G; Brown MA; Cho TJ; De Cunto C; Delai P; Haga N; Morhart R; Scott C; Zhang K; Diecidue RJ; Friedman CS; Kaplan FS; Eekhoff EMW
Br J Clin Pharmacol; 2019 Jun; 85(6):1199-1207. PubMed ID: 30281842
[TBL] [Abstract][Full Text] [Related]
33. Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1.
Whyte MP; Wenkert D; Demertzis JL; DiCarlo EF; Westenberg E; Mumm S
J Bone Miner Res; 2012 Mar; 27(3):729-37. PubMed ID: 22131272
[TBL] [Abstract][Full Text] [Related]
34. Fibrodysplasia ossificans progressiva in a young adult with genetic mutation: Case report.
Wang Z; Wang X; Liu B; Hou Y
Medicine (Baltimore); 2021 Mar; 100(9):e24620. PubMed ID: 33655926
[TBL] [Abstract][Full Text] [Related]
35. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.
Kitterman JA; Kantanie S; Rocke DM; Kaplan FS
Pediatrics; 2005 Nov; 116(5):e654-61. PubMed ID: 16230464
[TBL] [Abstract][Full Text] [Related]
36. Fibroplasia Ossificans Progressiva: A Case Report of a Rare Disease Entity.
Solomon D; Wakjira I; Hailu D; Gorfy Y
Ethiop J Health Sci; 2018 Jul; 28(4):513-516. PubMed ID: 30607064
[TBL] [Abstract][Full Text] [Related]
37. Difficult diagnosis and genetic analysis of fibrodysplasia ossificans progressiva: a case report.
Tian S; Zhu J; Lu Y
BMC Med Genet; 2018 Feb; 19(1):30. PubMed ID: 29482508
[TBL] [Abstract][Full Text] [Related]
38. Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry.
Pignolo RJ; Cheung K; Kile S; Fitzpatrick MA; De Cunto C; Al Mukaddam M; Hsiao EC; Baujat G; Delai P; Eekhoff EMW; Di Rocco M; Grunwald Z; Haga N; Keen R; Levi B; Morhart R; Scott C; Sherman A; Zhang K; Kaplan FS
Bone; 2020 May; 134():115274. PubMed ID: 32062004
[TBL] [Abstract][Full Text] [Related]
39. The congenital great toe malformation of fibrodysplasia ossificans progressiva? - A close call.
Towler OW; Shore EM; Xu M; Bamford A; Anderson I; Pignolo RJ; Kaplan FS
Eur J Med Genet; 2017 Jul; 60(7):399-402. PubMed ID: 28473268
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of TGFβ signaling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease.
Micha D; Voermans E; Eekhoff MEW; van Essen HW; Zandieh-Doulabi B; Netelenbos C; Rustemeyer T; Sistermans EA; Pals G; Bravenboer N
Bone; 2016 Mar; 84():169-180. PubMed ID: 26769004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
